Kyowa Hakko Kirin Co., Ltd. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Guidance for the Half Year Ending June 2014 and Full Year Ending December 2014
January 31, 2014 at 09:20 pm IST
Share
Kyowa Hakko Kirin Co., Ltd. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company's net sales were JPY 88.5 billion against JPY 88.4 billion for the same period a year ago. Operating income was JPY 10.3 billion against JPY 15.5 billion for the same period a year ago. Ordinary income was JPY 10.2 billion against JPY 16.4 billion for the same period a year ago. Income before income taxes and minority interest was JPY 9.2 billion against JPY 13.6 billion for the same period a year ago. Net income was JPY 6.7 billion or JPY 16.57 per share prior to amortization of goodwill against JPY 8.7 billion or JPY 20.23 per share prior to amortization of goodwill for the same period a year ago.
For the year, the company's net sales were JPY 340.6 billion against JPY 333.1 billion for the same period a year ago. Operating income was JPY 51.7 billion against JPY 52.9 billion for the same period a year ago. Ordinary income was JPY 49.5 billion against JPY 49.0 billion for the same period a year ago. Income before income taxes and minority interest was JPY 49.7 billion against JPY 45.0 billion for the same period a year ago. Net income was JPY 30.0 billion or JPY 71.85 per share prior to amortization of goodwill against JPY 24.1 billion or JPY 61.00 per share prior to amortization of goodwill for the same period a year ago. Capital expenditure was JPY 24.8 billion against JPY 19.7 billion reported last year. Cash flow from operating activities was JPY 56.8 billion against JPY 59.1 billion reported last year. Purchase of property, plant and equipment was JPY 21.5 billion against JPY 17.5 billion reported last year. Purchase of intangible assets was JPY 13.1 billion against JPY 9.3 billion reported last year.
For the half year ending June 2014, the company expects to report net sales of JPY 163.0 billion, operating income of JPY 16.0 billion.
For the full year ending December 2014, the company expects to report net sales of JPY 337.0 billion, operating income of JPY 41.0 billion, ordinary income of JPY 35.0 billion, income before income taxes and minority interest of JPY 34.5 billion and net income of JPY 20.0 billion or JPY 53.45 per share prior to amortization of goodwill.
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Kyowa Hakko Kirin Co., Ltd. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Guidance for the Half Year Ending June 2014 and Full Year Ending December 2014